Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.06. | Sonnet Biotherapeutics erhält Delisting-Mitteilung von der NASDAQ | 5 | Investing.com Deutsch | ||
02.06. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
01.05. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit | 2 | GlobeNewswire (USA) | ||
16.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Releases Virtual Investor "What This Means" Segment | 4 | GlobeNewswire (USA) | ||
04.04. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
04.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest ... | 257 | GlobeNewswire (Europe) | Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq®) The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg in combination... ► Artikel lesen | |
SONNET BIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
01.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Announces Release of Corporate Update Video | 3 | GlobeNewswire (USA) | ||
01.04. | Sonnet BioTherapeutics ernennt Interims-CEO nach dem Tod des Gründers | 2 | Investing.com Deutsch | ||
01.04. | Sonnet BioTherapeutics appoints interim CEO after founder's death | 3 | Investing.com | ||
01.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. | 183 | GlobeNewswire (Europe) | PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted... ► Artikel lesen | |
26.03. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas | 209 | GlobeNewswire (Europe) | SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy... ► Artikel lesen | |
26.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
19.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
19.03. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant ... | 200 | GlobeNewswire (Europe) | Company advancing development of its modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable... ► Artikel lesen | |
26.02. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors | 4 | GlobeNewswire (USA) | ||
26.02. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
19.02. | Sonnet BioTherapeutics advances novel ADC platform | 1 | Investing.com | ||
19.02. | Sonnet BioTherapeutics macht Fortschritte bei neuartiger ADC-Plattform | 1 | Investing.com Deutsch | ||
19.02. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline ... | 121 | GlobeNewswire (Europe) | Building on proven targeting of the FHAB domain, Sonnet's ADC platform offers flexible payload capacity and controllable drug-antibody ratios (DAR) An epidermal growth factor receptor 2 (HER2) ADC... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
KRAFT HEINZ | 21,820 | -0,30 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
BEYOND MEAT | 2,910 | -0,24 % | Diese Billionen-Disruption ist auch fürs Depot nachhaltig: Argo Living Soils, Beyond Meat, Heidelberg Materials | Anzeige / WerbungInvestoren haben es schon einmal erlebt: Aus ambitionierten Plänen und großen Revolutionen wird am Ende nichts. Zumindest nicht aus Anleger-Sicht. Bestes Beispiel: Die vegane Revolution... ► Artikel lesen | |
MODERN PLANT BASED FOODS | 0,040 | +1,53 % | Modern Plant Based Foods Inc (2): Modern Plant Based Foods arranges $230,000 financing | ||
LUCKIN COFFEE | 31,200 | +4,00 % | Luckin Coffee Inc. Reveals Climb In Q4 Profit | BEIJING (dpa-AFX) - Luckin Coffee Inc. (LKNCY) reported a profit for its fourth quarter that increased from the same period last yearThe company's bottom line totaled RMB841.13 million, or RMB2.64... ► Artikel lesen | |
SUNWIN STEVIA INTERNATIONAL | 0,014 | 0,00 % | SUNWIN STEVIA INTERNATIONAL, INC. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
YUM! BRANDS | 124,95 | -1,42 % | Märkte am Morgen: Heidelberg Materials, BYD, Nvidia, Aerovironment, Yum! Brands, Micron Technology | Starke Zahlen von Micron: Gewinn und Umsatz übertreffen die Erwartungen deutlich, auch der Ausblick überzeugt. Shell sorgt für Schlagzeilen - angebliche Gespräche über eine 80-Milliarden-Dollar-Übernahme... ► Artikel lesen | |
CHIPOTLE MEXICAN GRILL | 47,515 | +1,07 % | Working While Working Out-Chipotle And Starbucks CEOs Share Ideas On How To Improve Their Companies During Daily 5 A.M. Workouts | ||
KROGER | 60,67 | -0,57 % | Gamechanger-News: Diese Aktie zündet den nächsten Turbo: Neue Tochterfirma könnte alles verändern! | ||
OATLY GROUP | 9,900 | -0,80 % | Oatly AB: Oatly to Report Second Quarter 2025 Financial Results on July 23, 2025 | ||
DOMINOS PIZZA INC | 378,95 | -0,60 % | Here's What to Expect From Domino's Pizza's Next Earnings Report | ||
VILLAGE FARMS | 0,928 | +0,98 % | Village Farms International, Inc.: Village Farms International Regains NASDAQ Compliance | VANCOUVER, British Columbia, June 09, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) today announced that it received formal notice from... ► Artikel lesen | |
BLENDER BITES | 0,128 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
CAVA GROUP | 84,61 | +8,61 % | Can CAVA's Measured Marketing Strategy Fuel the Next Phase of Growth? | ||
MCDONALDS | 248,50 | -0,26 % | McDonald's price target lowered to $325 at KeyBanc on consumer spending | ||
KATJES | 108,25 | 0,00 % | ANLEIHEN-Woche KW15 - 2025: Iute Group, Hertha BSC, Katjes International, Karlsberg, Mutares, UBM, Schalke 04, FCR Immobilien, Domaines Kilger, ESPG, WeGrow, … |